SCHEMBL6637809

SCHEMBL6637809

NCC1CCC(N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5545207 1.00
SCHEMBL5545205 1.00
Hydrochloric Acid SCHEMBL29121443 0.97
SCHEMBL6428359 0.85 PLG (0.32)
SCHEMBL24713485 0.83
SCHEMBL1762443 0.83
SCHEMBL1577716 0.83
SCHEMBL1577714 0.83
SCHEMBL1577711 0.83
SCHEMBL1762444 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240042000-A1 CARBOHYDRATE STRUCTURES AND USES THEREOF 6452728 CANADA CORP (CA) 2024-02-08 US claimed
US-11786586-B2 Carbohydrate structures and uses thereof AOA DX (US) 2023-10-17 US claimed
US-20190343941-A1 CARBOHYDRATE STRUCTURES AND USES THEREOF AOA DX 2019-11-14 US claimed
WO-2018112669-A1 GANGLIOSIDE CARBOHYDRATE STRUCTURES AND USES THEREOF REALIST PHARMA, INC. (CA) 2018-06-28 WO claimed
US-20250277793-A1 COMPOSITIONS AND METHODS FOR CANCER DIAGNOSIS AOA DX 2025-09-04 US disclosed
US-12043755-B2 Compositions, methods, and articles relating to in-situ crosslinking of polyamides during additive manufacturing XEROX CORPORATION (US) 2024-07-23 US disclosed
US-20240042000-A1 CARBOHYDRATE STRUCTURES AND USES THEREOF 6452728 CANADA CORP (CA) 2024-02-08 US disclosed
CN-117120086-A Compositions and methods for cancer diagnosis AOA DX公司 2023-11-24 CN disclosed
US-11786586-B2 Carbohydrate structures and uses thereof AOA DX (US) 2023-10-17 US disclosed
WO-2023192801-A1 SULFONAMIDO DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
EP-4225365-A1 COMPOSITIONS AND METHODS FOR CANCER DIAGNOSIS AOA Dx (US) 2023-08-16 EP disclosed
US-20230014658-A1 COMBINATORIAL PHOTO-CONTROLLED SPATIAL SEQUENCING AND LABELING UNIVERSITY OF WASHINGTON (US) 2023-01-19 US disclosed
US-6743794-B2 MULTIDRUG RESISTANCE PROTEIN; CANCER; 3-(9-CHLORO-3-METHYL-4-OXO-5H-ISOXAZOLO(4,3-C)QUINOLIN-5-YL)) CYCLOHEXYL)-2-PIPERIDYLACETAMIDE ELI LILLY AND COMPANY 2004-06-01 US disclosed
US-20030100576-A1 Methods and compounds for inhibiting mrp1 ELI LILLY AND COMPANY 2003-05-29 US disclosed
EP-1250340-A1 METHODS AND COMPOUNDS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2002-10-23 EP disclosed
WO-2001046199-A1 METHODS AND COMPOUNDS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2001-06-28 WO disclosed
US-6100430-A ALICYCLIC COMPOUND CONTAINING TWO PRIMARY, SECONDARY AND/OR TERTIARY AMINO GROUPS AND HAVING A CARBON ATOM IN THE RING SUBSTITUTED WITH TWO ALKYL GROUPS; MAKING BY REDUCTIVE AMINATION OF A 3-FORMYLCYCLOALKENONE OR 3-FORMYLCYCLOALKANONE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
EP-0976723-A2 A cycloaliphatic polyisocyanate compound, a process for the preparation thereof, a polyurethane therefrom, and an adhesive composition Daicel Chemical Industries, Ltd. (JP) 2000-02-02 EP disclosed
EP-0895984-A1 ALICYCLIC POLYAMINES AND PROCESS FOR THE PREPARATION THEREOF DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-02-10 EP disclosed
US-3996201-A MOLDING CIBA-GEIGY CORPORATION (US) 1976-12-07 US disclosed